Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

BACKGROUND: Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and benzodiazepine anxiolytics are used in the US to treat generalized anxiety disorder (GAD). While benzodiazepines typically provide rapid symptomatic relief, long-term use is not recommended due to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Berger, Ariel, Edelsberg, John, Treglia, Michael, Alvir, Jose Ma J, Oster, Gerry
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3504522/
https://ncbi.nlm.nih.gov/pubmed/23088742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-12-177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados